[1]
T. Poolthawee and B. Ruksalikit, “Effectiveness and side effects of pegylated interferon/ribavirin and direct acting antiviral: DAA in chronic hepatitis C patients in Lampang hospital”, J Nakornping Hosp, vol. 11, no. 1, Jul. 2020.